characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2023-02-14T00:24:42Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2023-02-14T00:24:42Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA112365011
characteristics.characteristic: External Id
characteristics.text: Columbia University Irving Medical Center
characteristics.characteristic: INSDC center name
characteristics.text: 2023-02-14T00:24:42Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-02-14T00:24:42Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS14475346
characteristics.characteristic: SRA accession
characteristics.text: Dd2_C5
characteristics.characteristic: Submitter Id
characteristics.text: Compound 49 resistant clone C5
characteristics.characteristic: description
characteristics.text: asexual blood stage
characteristics.characteristic: dev_stage
characteristics.text: Plasmodium falciparum Dd2
characteristics.characteristic: organism
characteristics.text: David Fidock
characteristics.characteristic: provider
characteristics.text: df2260@cumc.columbia.edu
characteristics.characteristic: provider_contact
characteristics.text: Plasmodium falciparum Dd2
characteristics.characteristic: scientific_name
characteristics.text: Dd2
characteristics.characteristic: strain
characteristics.text: Dd2-C5
characteristics.characteristic: title